食管癌新辅助治疗后手术的复发与生存:单中心十年经验
该单中心回顾性研究分析了2013年9月至2023年9月连续222例接受新辅助放化疗后微创Ivor Lewis食管切除术的食管癌患者,采用Cox回归探索复发与生存相关因素。多因素分析显示N分期和细胞分化程度是复发的独立危险因素,高龄和细胞分化程度是总生存的独立危险因素。
要点
- N分期和细胞分化程度是复发的独立危险因素。
- 高龄和细胞分化程度是总生存的独立危险因素。
- 基于风险因素可辅助治疗选择与共享决策。
核心结论
- 高龄和细胞分化程度是总生存的强独立危险因素。
- N分期和年龄是与复发和生存均相关的强独立危险因素。
研究设计与样本
- 回顾性分析前瞻性收集的连续病例数据。
- 纳入2013年9月至2023年9月接受新辅助放化疗后微创Ivor Lewis食管切除术的222例食管癌患者。
- 采用单因素和多因素Cox比例风险回归模型探索复发无生存和总生存的危险与保护因素。
主要发现
- 单因素分析中,高血压、ECOG评分、N分期、阳性淋巴结数目、淋巴血管侵犯、细胞分化和切缘阳性与复发相关。
- 单因素分析中,年龄、N分期、阳性淋巴结数目、淋巴血管侵犯和细胞分化与更差的总生存相关。
- 多因素分析中,N分期(1.911 [1.295-2.819],P = .009)和细胞分化程度恶化(2.042 [1.036-4.025],P = .039)是复发的危险因素。
- 多因素分析中,高龄(1.056 [1.013-1.102],P = .011)和细胞分化(1.949 [1.004-3.782],P = .049)与更高的死亡风险显著相关。
临床怎么用
- 可利用N分期、年龄和细胞分化程度等风险因素指导治疗选择和共享决策,以最大化无复发生存和总生存。
局限性
- 单中心回顾性研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Standard of care for locally advanced esophageal cancer is neoadjuvant therapy followed by surgical resection. The objective of this study is to explore perioperative factors associated with recurrence and survival among patients with locally advanced esophageal cancer. METHODS: A retrospective analysis of prospectively collected data on all consecutive minimally invasive Ivor Lewis esophagectomy cases for esophageal cancer performed from September 2013 to September 2023 was performed. Univariable and multivariable Cox proportional hazard regression models were used explore the risk and protective factors associated with recurrence-free and overall survival. RESULTS: In total, 222 consecutive patients who underwent neoadjuvant chemoradiation followed by minimally invasive Ivor Lewis esophagectomy were included. On univariable analysis, hypertension, Eastern Cooperative Oncologic Group, N stage, number of positive lymph nodes, lymphovascular invasion, cellular differentiation, and positive margins were associated with recurrence. Age, N stage, number of positive lymph nodes, lymphovascular invasion, and cellular differentiation were associated with a worse overall survival. On multivariable analysis, N stage (1.911 [1.295-2.819], P = .009) and worsening cellular differentiation (2.042 [1.036-4.025], P = .039) remained risk factors for recurrence, whereas older age (1.056 [1.013-1.102], P = .011) and cellular differentiation (1.949 [1.004-3.782], P = .049) remained significantly associated with a greater risk of death. CONCLUSION: Our data suggest that older age and cellular differentiation are strong independent risk factors associated with overall survival. N stage and age are strong independent risk factors associated with both recurrence and survival. These findings may help guide treatment options and shared decision-making among patients with locally advanced esophageal cancer on the basis of their risk and protective factors to maximize recurrence-free and overall survival.
引用
- Ramos-Fresnedo A, Phillips AL, Cantrell MC, et al. Cancer recurrence and survival among patients who underwent neoadjuvant treatment and surgery for esophageal cancer: A single-institution 10-year experience. Surgery. 2024. PMID: 39490255. doi:10.1016/j.surg.2024.07.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。